These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
175 related items for PubMed ID: 19040711
1. Connective tissue growth factor and cardiac fibrosis. Daniels A, van Bilsen M, Goldschmeding R, van der Vusse GJ, van Nieuwenhoven FA. Acta Physiol (Oxf); 2009 Mar; 195(3):321-38. PubMed ID: 19040711 [Abstract] [Full Text] [Related]
2. Connective tissue growth factor: growth factor, matricellular organizer, fibrotic biomarker or molecular target for anti-fibrotic therapy in SSc? Abraham D. Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v8-9. PubMed ID: 18784153 [Abstract] [Full Text] [Related]
3. [Connective tissue growth factor (CTGF): a key factor in the onset and progression of kidney damage]. Sánchez-López E, Rodrigues Díez R, Rodríguez Vita J, Rayego Mateos S, Rodrigues Díez RR, Rodríguez García E, Lavoz Barria C, Mezzano S, Egido J, Ortiz A, Ruiz-Ortega M, Selgas R. Nefrologia; 2009 Oct; 29(5):382-91. PubMed ID: 19820749 [Abstract] [Full Text] [Related]
4. Expression of connective tissue growth factor in acute heart allograft rejection in rats. Yuan YC, Xia ZK, Zhang QC, Yin BL. Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 May; 33(5):425-31. PubMed ID: 18544847 [Abstract] [Full Text] [Related]
6. Cardiac tissue factor: roles in physiology and fibrosis. Davis DR, Erlich JH. Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):342-8. PubMed ID: 18290875 [Abstract] [Full Text] [Related]
7. Down-regulation of miR-15a/b accelerates fibrotic remodelling in the Type 2 diabetic human and mouse heart. Rawal S, Munasinghe PE, Nagesh PT, Lew JKS, Jones GT, Williams MJA, Davis P, Bunton D, Galvin IF, Manning P, Lamberts RR, Katare R. Clin Sci (Lond); 2017 May 01; 131(9):847-863. PubMed ID: 28289072 [Abstract] [Full Text] [Related]
8. Fluvastatin attenuates myocardial interstitial fibrosis and cardiac dysfunction in diabetic rats by inhibiting over-expression of connective tissue growth factor. Dai QM, Lu J, Liu NF. Chin Med J (Engl); 2011 Jan 01; 124(1):89-94. PubMed ID: 21362314 [Abstract] [Full Text] [Related]
9. Circulating transforming growth factor beta-1: a partial molecular explanation for associations between hypertension, diabetes, obesity, smoking and human disease involving fibrosis. Peterson MC. Med Sci Monit; 2005 Jul 01; 11(7):RA229-32. PubMed ID: 15990699 [Abstract] [Full Text] [Related]
10. Role of connective tissue growth factor in experimental radiation nephropathy in rats. Liu DG, Wang TM. Chin Med J (Engl); 2008 Oct 05; 121(19):1925-31. PubMed ID: 19080126 [Abstract] [Full Text] [Related]
11. Osteopontin: a fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host. Szalay G, Sauter M, Haberland M, Zuegel U, Steinmeyer A, Kandolf R, Klingel K. Circ Res; 2009 Apr 10; 104(7):851-9. PubMed ID: 19246678 [Abstract] [Full Text] [Related]
12. Targeted disruption of Smad3 confers resistance to the development of dimethylnitrosamine-induced hepatic fibrosis in mice. Latella G, Vetuschi A, Sferra R, Catitti V, D'Angelo A, Zanninelli G, Flanders KC, Gaudio E. Liver Int; 2009 Aug 10; 29(7):997-1009. PubMed ID: 19422482 [Abstract] [Full Text] [Related]
13. Matricellular proteins: new molecular targets to prevent heart failure. Okamoto H, Imanaka-Yoshida K. Cardiovasc Ther; 2012 Aug 10; 30(4):e198-209. PubMed ID: 21884011 [Abstract] [Full Text] [Related]
14. Connective tissue growth factor: context-dependent functions and mechanisms of regulation. Cicha I, Goppelt-Struebe M. Biofactors; 2009 Aug 10; 35(2):200-8. PubMed ID: 19449449 [Abstract] [Full Text] [Related]
15. Edema and fluid dynamics in connective tissue remodelling. Reed RK, Lidén A, Rubin K. J Mol Cell Cardiol; 2010 Mar 10; 48(3):518-23. PubMed ID: 19595693 [Abstract] [Full Text] [Related]
16. Connective tissue growth factor and cardiac diastolic dysfunction: human data from the Taiwan diastolic heart failure registry and molecular basis by cellular and animal models. Wu CK, Wang YC, Lee JK, Chang SN, Su MY, Yeh HM, Su MJ, Chen JJ, Chiang FT, Hwang JJ, Lin JL, Tsai CT. Eur J Heart Fail; 2014 Feb 10; 16(2):163-72. PubMed ID: 24464932 [Abstract] [Full Text] [Related]
17. Smad3 loss confers resistance to the development of trinitrobenzene sulfonic acid-induced colorectal fibrosis. Latella G, Vetuschi A, Sferra R, Zanninelli G, D'Angelo A, Catitti V, Caprilli R, Flanders KC, Gaudio E. Eur J Clin Invest; 2009 Feb 10; 39(2):145-56. PubMed ID: 19200168 [Abstract] [Full Text] [Related]
18. N-terminal domains of CCN family 2/connective tissue growth factor bind to aggrecan. Aoyama E, Hattori T, Hoshijima M, Araki D, Nishida T, Kubota S, Takigawa M. Biochem J; 2009 May 27; 420(3):413-20. PubMed ID: 19298220 [Abstract] [Full Text] [Related]
19. Endothelin receptor selectivity: evidence from in vitro and pre-clinical models of scleroderma. Shiwen X, Leask A, Abraham DJ, Fonseca C. Eur J Clin Invest; 2009 Jun 27; 39 Suppl 2():19-26. PubMed ID: 19335743 [Abstract] [Full Text] [Related]
20. Expression and role of connective tissue growth factor in painful disc fibrosis and degeneration. Peng B, Chen J, Kuang Z, Li D, Pang X, Zhang X. Spine (Phila Pa 1976); 2009 Mar 01; 34(5):E178-82. PubMed ID: 19247157 [Abstract] [Full Text] [Related] Page: [Next] [New Search]